Teva Pharmaceutical Industries Ltd (TEVJF) Gross Profit (2009 - 2026)

Teva Pharmaceutical Industries' (TEVJF) quarterly Gross Profit came in at $2.2 billion in Q2 2026, up 2.43% YoY from $2.1 billion in Q2 2025, and up 9.18% on a QoQ basis from $2.0 billion in Q1 2026.

Teva Pharmaceutical Industries Ltd (TEVJF) Gross Profit (2009 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVJF) has 18 years of Gross Profit data on file, last reported at $2.2 billion in Q2 2026.

  • Quarterly Gross Profit rose 2.43% year-over-year to $2.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.1 billion (up 10.15% YoY) and the FY2025 annual result came in at $8.9 billion, up 10.84% from the prior year.
  • Gross Profit rose to $2.2 billion in Q2 2026, from $2.0 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $2.7 billion in Q4 2025 to a low of $1.6 billion in Q1 2023.
  • A 5-year average of $2.0 billion and a median of $1.9 billion in 2025 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2022 — Gross Profit decreased 13.66% — and 2023, when it jumped 36.5%.
  • Tracing TEVJF's Gross Profit over 5 years: stood at $1.8 billion in 2022, then soared by 36.5% to $2.4 billion in 2023, then slipped by 12.21% to $2.1 billion in 2024, then grew by 25.22% to $2.7 billion in 2025, then slipped by 18.94% to $2.2 billion in 2026.
  • The last three Gross Profit figures came in at $2.2 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.7 billion (Q4 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 2.15 Bn
Jun 30, 2026 2.15 Bn
Mar 31, 2026 1.97 Bn
Mar 31, 2026 1.97 Bn
Dec 31, 2025 2.66 Bn
Dec 31, 2025 2.66 Bn
Sep 30, 2025 2.30 Bn
Sep 30, 2025 2.30 Bn
Jun 30, 2025 2.10 Bn
Jun 30, 2025 2.10 Bn
Mar 31, 2025 1.88 Bn
Mar 31, 2025 1.88 Bn
Dec 31, 2024 2.12 Bn
Dec 31, 2024 2.12 Bn
Sep 30, 2024 2.15 Bn
Sep 30, 2024 2.15 Bn
Jun 30, 2024 2.02 Bn
Jun 30, 2024 2.02 Bn
Mar 31, 2024 1.77 Bn
Mar 31, 2024 1.77 Bn